Bo Lak (002760) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bo Lak (002760) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.89 Billion ≈ $1.28 Million USD) by net assets (₩48.59 Billion ≈ $32.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bo Lak - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Bo Lak's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002760 current and long-term liabilities for a breakdown of total debt and financial obligations.
Bo Lak Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bo Lak ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DONGJIANG ENVIRONMENTAL H
F:DGN
|
N/A |
|
Rapala VMC Oyj
HE:RAP1V
|
0.083x |
|
CZR Resources Ltd
AU:CZR
|
-0.033x |
|
SGA Solutions Co.Ltd
KQ:184230
|
0.259x |
|
Yuyu Pharma
KO:000220
|
0.006x |
|
Aerodrome Group Ltd
TA:ARDM
|
-0.198x |
|
Charnic Capital Tbk PT
JK:NICK
|
0.139x |
|
NexLiving Communities Inc
V:NXLV
|
0.039x |
Annual Cash Flow Conversion Efficiency for Bo Lak (2013–2024)
The table below shows the annual cash flow conversion efficiency of Bo Lak from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Bo Lak (002760) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩46.65 Billion ≈ $31.61 Million |
₩904.07 Million ≈ $612.68K |
0.019x | -37.93% |
| 2023-12-31 | ₩48.78 Billion ≈ $33.06 Million |
₩1.52 Billion ≈ $1.03 Million |
0.031x | -40.73% |
| 2022-12-31 | ₩48.38 Billion ≈ $32.79 Million |
₩2.55 Billion ≈ $1.73 Million |
0.053x | +103.71% |
| 2021-12-31 | ₩45.54 Billion ≈ $30.86 Million |
₩1.18 Billion ≈ $798.04K |
0.026x | -43.95% |
| 2020-12-31 | ₩44.00 Billion ≈ $29.82 Million |
₩2.03 Billion ≈ $1.38 Million |
0.046x | +38.55% |
| 2019-12-31 | ₩43.95 Billion ≈ $29.78 Million |
₩1.46 Billion ≈ $991.60K |
0.033x | -56.85% |
| 2018-12-31 | ₩43.76 Billion ≈ $29.66 Million |
₩3.38 Billion ≈ $2.29 Million |
0.077x | +372.55% |
| 2017-12-31 | ₩43.22 Billion ≈ $29.29 Million |
₩705.78 Million ≈ $478.30K |
0.016x | -87.20% |
| 2016-12-31 | ₩42.75 Billion ≈ $28.97 Million |
₩5.45 Billion ≈ $3.69 Million |
0.128x | +60.24% |
| 2015-12-31 | ₩40.01 Billion ≈ $27.11 Million |
₩3.18 Billion ≈ $2.16 Million |
0.080x | -9.82% |
| 2014-12-31 | ₩41.13 Billion ≈ $27.88 Million |
₩3.63 Billion ≈ $2.46 Million |
0.088x | +73.87% |
| 2013-12-31 | ₩39.25 Billion ≈ $26.60 Million |
₩1.99 Billion ≈ $1.35 Million |
0.051x | -- |
About Bo Lak
Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docet… Read more